V6X-11773-01299
3 vaccinations
5 coded responses
30 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 372 / TN
- Registered
- 2022-07-01
- Relationship
- Child or adolescent in my care
- Guardian
- A86-14178-86488
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-01
Registered in v-safe
-
2022-07-01
Dose 1 — Moderna
- 2022-07-02
- 2022-07-04
- 2022-07-05
- 2022-07-07
- 2022-07-08
- 2022-07-15
-
2022-07-22
Survey response — day 21, dose 1, under 3MedDRA: Pyrexia, Rash — Feeling: Good · Be unable to work or attend schoolFree text: Mild rash, low feverMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Dose 2 — Moderna
- 2022-07-29
- 2022-07-30
- 2022-07-31
- 2022-08-02
- 2022-08-03
- 2022-08-05
-
2022-08-12
Survey response — day 14, dose 2, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Mild fever, mild cough, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-08-19
- 2022-08-26
- 2022-09-02
-
2022-09-11
Survey response — day 42, dose 2, under 3MedDRA: Pyrexia — Feeling: GoodFree text: Low grade feverMedDRA releases: 2024-11 · check-in free text available
- 2022-10-28
-
2023-01-24
Dose 3 — ModernaCo-administered: Hepatitis A:Other:Tetanus
- 2023-01-27
-
2023-01-27
Survey response — 6 months, dose 2, under 3MedDRA: Diarrhoea, Pyrexia, Viral infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-01-29
- 2023-01-30
- 2023-01-31
-
2023-02-09
Survey response — day 14, dose 3, under 3MedDRA: Cough, Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
- 2023-02-16
- 2023-02-21
- 2023-02-28
- 2023-03-07
- 2023-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-01 | Moderna | No |
| 2 | 2022-07-29 | Moderna | No |
| 3 | 2023-01-24 | Moderna | Hepatitis A:Other:Tetanus |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Mild rash, low fever
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Mild fever, mild cough, runny nose
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Low grade fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release